Conference
Next Generation BTK Inhibitor Acalabrutinib with Bendamustine-Rituximab in First Line Waldenstrom's Macroglobulinemia: The Brawm Study
Authors
Berinstein NL; Klein G; Welsh K; McClure R; Forward NA; Shafey M; Nikonova A; MacDonald D; Villa D; Sandhu I
Volume
140
Pagination
pp. 9383-9384
Publisher
American Society of Hematology
Publication Date
November 15, 2022
DOI
10.1182/blood-2022-169245
Conference proceedings
Blood
Issue
Supplement 1
ISSN
0006-4971